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Abstract
Background: The uptake and intracellular trafficking of sphingolipids, which self-associate into plasma membrane
microdomains, is associated with many pathological conditions, including viral and toxin infection, lipid storage disease, and
neurodegenerative disease. However, the means available to label the trafficking pathways of sphingolipids in live cells are
extremely limited. In order to address this problem, we have developed an exogenous, non-toxic probe consisting of a 25-
amino acid sphingolipid binding domain, the SBD, derived from the amyloid peptide Ab, and conjugated by a neutral linker
with an organic fluorophore. The current work presents the characterization of the sphingolipid binding and live cell
trafficking of this novel probe, the SBD peptide. SBD was the name given to a motif originally recognized by Fantini et al [1]
in a number of glycolipid-associated proteins, and was proposed to interact with sphingolipids in membrane microdomains.
Methodology/Principal Findings: In accordance with Fantini’s model, optimal SBD binding to membranes depends on the
presence of sphingolipids and cholesterol. In synthetic membrane binding assays, SBD interacts preferentially with raft-like
lipid mixtures containing sphingomyelin, cholesterol, and complex gangliosides in a pH-dependent manner, but is less
glycolipid-specific than Cholera toxin B (CtxB). Using quantitative time-course colocalization in live cells, we show that the
uptake and intracellular trafficking route of SBD is unlike that of either the non-raft marker Transferrin or the raft markers
CtxB and Flotillin2-GFP. However, SBD traverses an endolysosomal route that partially intersects with raft-associated
pathways, with a major portion being diverted at a late time point to rab11-positive recycling endosomes. Trafficking of SBD
to acidified compartments is strongly disrupted by cholesterol perturbations, consistent with the regulation of sphingolipid
trafficking by cholesterol.
Conclusions/Significance: The current work presents the characterization and trafficking behavior of a novel sphingolipid-
binding fluorescent probe, the SBD peptide. We show that SBD binding to membranes is dependent on the presence of
cholesterol, sphingomyelin, and complex glycolipids. In addition, SBD targeting through the endolysosomal pathway in
neurons is highly sensitive to cholesterol perturbations, making it a potentially useful tool for the analysis of sphingolipid
trafficking in disease models that involve changes in cholesterol metabolism and storage.
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Introduction
Sphingolipids segregate into nano-scaled domains at the plasma
membrane, commonly referred to as lipid rafts, which are defined
by high sphingolipid and cholesterol content, and low buoyant
density in high-speed ultracentrifugation gradients [2–5]. Rafts are
now thought to include a variety of plasma membrane domains
with different characteristics that invaginate into endocytic vesicles
[6–11].
A method that would allow the tracking of intracellular
pathways taken by raft-borne sphingolipids is of general interest,
because of their involvement in a number of biologically and
clinically important processes. Sphingolipid and cholesterol
trafficking is altered in the cells of patients with Niemann Pick
disease, and a number of other lipid storage diseases where
sphingolipids accumulate in late endosomal and lysosomal
compartments [12–14]. Cholesterol and sphingolipids such as
ceramide, sphingomyelin, and gangliosides are also thought to be
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viruses and pathogens, including the Alzheimer’s associated
amyloid peptide, recognize specific carbohydrate-containing
headgroups of glycosphingolipids [19–22], a large variety of
which are expressed on the surfaces of cells and occupy membrane
microdomains [23–27]. Therefore, a sphingolipid-targeted, exog-
enous probe for live imaging studies would be a useful tool in
studying diseases whose pathogenesis is glycosphingolipid-depen-
dent. Currently, non-invasive small-molecule tracers that can be
used to visualize the binding and trafficking of sphingolipid-
containing microdomains are not available.
The most commonly used sphingolipid-binding probe, Cholera
toxin B (CtxB), may be atypical in that it can be internalized by
both non-clathrin and clathrin-dependent uptake mechanisms
[28–30]. It is also important to consider that CtxB induces
clustering of sphingolipids [31–33], and binds very tightly and
specifically to a single target glycolipid, GM1 [34]. CtxB and
another common microdomain tracer, the glycosyl-phosphatidyl-
inositol (GPI)-anchor fused to fluorescent protein, both traffic
primarily to the Golgi [35] (although this has been contested [36]),
and may occupy primarily non-raft domains [37,38]. Other
tracers of non-clathrin uptake pathways currently in use are green
fluorescent protein (GFP) fusions of the endocytic adaptors Flotillin
and caveolin [39–41]. Fluorescent protein fusions have the
disadvantage that they must be expressed from transgenes, and
therefore may fluoresce in the biosynthetic pathway. Additionally,
these endocytic adaptor proteins are not found universally in all
cell types, and correspond to a specific subtype of membrane
microdomain [11].
With this background, our goal was to generate a probe with
which one could monitor changes in raft-derived sphingolipid
trafficking that occur in lipid-related and neurodegenerative
disease states. To this end, we created a small fluorescently
coupled peptide probe consisting of a domain, the sphingolipid
binding domain, SBD, which Fantini and coworkers identified in
the sequences of several proteins that were known to bind to cell-
surface glycosphingolipids [22]. The Alzheimer’s disease-associat-
ed Ab peptide contains a variant of the V3 loop domain, which is
also found in HIV-1 gp120 and the Prion protein (Prp) (ibid). This
domain can bind to synthetic membranes containing sphingolipids
[22,42–45] and associations have been reported between V3 loop-
bearing proteins and gangliosides [21,22,46–50]. In a previous
study [51] we reported that a myc-tagged version of the 25 amino
acid SBD peptide derived from Ab [22] is associated with
detergent-resistant membranes in neurons, and showed that
cholesterol depletion inhibits uptake and alters the diffusion
behavior of fluorescently tagged SBD at the plasma membrane,
which is normally slow. In that study, we also demonstrated a
dependence on sphingolipids for endocytosis, and an interaction
with immobilized sphingolipids in fat blots.
Here, we present evidence in support of the idea that fluorescent
SBD acts as a sphingolipid tracer. Fluorophore-coupled SBD
binds preferentially to artificial membranes that contain a raft-like
mixture of sphingomyelin, cholesterol, and gangliosides. However,
SBD differs from CtxB in its ganglioside binding properties in that
it does not display a strong preference for a particular ganglioside.
Time-course quantitative colocalization of the SBD probe with a
variety of live fluorescent markers shows that SBD is rapidly
incorporated into early endosomes of mammalian and Drosophila
neurons. Similarly to fluorescent lactosyl-ceramide and other
sphingolipid-associated markers such as caveolin-GFP and CtxB
[52,53], SBD’s trafficking route is strongly altered by cholesterol
perturbations, but unlike these markers, it appears to cycle
between the endolysosomal and recycling pathways.
The fact that SBD labels Drosophila as well as mammalian
neurons effectively make it a useful tool for analyzing sphingolipid
trafficking pathways in disease models in this genetically tractable
organism. Although SBD is derived from the amyloid peptide Ab,
it is non-toxic, and can therefore be used to trace sphingolipid
trafficking pathways in a non-invasive way.
Results
I. SBD is recognized specifically and taken up by neuronal
cells in culture
A sphingolipid binding domain (SBD) peptide of 25aa was
generated based on a motif identified by Mahfoud et al, which
occurs in several viral and pathogenic proteins that co-purify with
glycosphingolipids [22,42]. The motif contained within the Ab
peptide was modified by a neutral diethylene glycol linker to
facilitate conjugation of fluorophores to the amino-terminus and to
minimize steric interference of the fluorophore with binding of the
peptide. SBD (fig. 1A; see Methods) was coupled to the small
molecule fluorophores Oregon Green (OG) and tetramethylrho-
damine (TMR) for live cell imaging.
Since the SBD marker has potential applications as a
sphingolipid trafficking tracer for cellular and animal models of
neurodegenerative disease, we examined the distribution of the
marker in several different cell types, including insect and
mammalian neurons.
Figure 1. SBD binds to and is internalized by insect and
mammalian cells. A. Sequences of the SBD, SBD*, and SBD
scr peptides
with amino-terminal Cysteine and AEEAc spacer. For SBD-TMR, the
fluorophore was conjugated directly via amine linkage to the spacer. B.
Drosophila c6 neuronal cells labelled with SBD-, SBD*-, or SBD
scr-Oregon
Green (conjugated with SBD at the terminal Cysteine) at 10 uM in HBSS
for 15 min at 25uC. Wild type SBD shows internalized punctae
representative of endocytic domains, whereas the number and intensity
of punctae in SBD* and SBD
scr are much reduced. C. Mouse NIH3T3
fibroblasts labelled with SBD-OG or SBD*-OG at 2 mM in HBSS for
15 min at 37uC. Scalebar in B=5 mm; in C=10 mm.
doi:10.1371/journal.pone.0002933.g001
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and above the range of concentrations used for labelling
experiments (see fig. S1 and Methods), was applied to adherent
mammalian NIH-3T3 fibroblasts, neuroblastoma SH-SY5Y [54],
and primary mouse cortical neurons [55]. Uptake after incubation
at physiological temperature was recorded by confocal and wide-
field fluorescence imaging in time-lapse. SBD is taken up rapidly
(,5 minutes) into vesicles that are similar in size and distribution
(fig. 1B, C) to endosomes labeled by Dextran and lysotracker (see
movie in neuroblastomas, fig. S4). SBD uptake and trafficking was
also analyzed in Drosophila neurons, because we are interested in
using it as a sphingolipid/microdomain-directed probe for analysis
of genetic disease models in the fly that affect sphingolipid
trafficking and storage. In Drosophila DL-DmBG2-c6 neurons
(hereafter called c6) [56], in contrast to mammalian cells, little
SBD fluorescence is seen at the plasma membrane, although SBD
is taken up readily by these neurons at physiological temperature
(25uC). At 4uC the labeling is inefficient, indicating that the
interaction of SBD with the plasma membrane is inhibited by low
temperature (not shown). SBD appears to have a higher affinity for
mammalian cells, since only about one-fifth of the concentration
was required for labelling as for Drosophila cells (fig. 1B, C; see
Methods). This is not surprising, since Drosophila do not produce
gangliosides [57], which are the presumed optimal receptors for
SBD, but they do have other glycolipids.
As a control for the specificity of the SBD interaction with the
plasma membrane, we also tested two mutated forms of the
peptide (fig. 1A): SBD* contains mutations in two amino acids
(R5RA and Y10RA) that were postulated by Fantini and
colleagues to mediate electrostatic and p-bonding interactions
with glycosphingolipids [22,42]; SBD
scr (scrambled) contains the
same amino acids as SBD in a random sequence. SBD* is taken up
less than half as efficiently as SBD, judging by the appearance of
,50% fewer punctae and lower fluorescence intensity within cells
(fig. 1B, C; quantitation not shown), whereas SBD
scr does not label
cells at all unless added at concentrations of 50 mM or more
(fig 1B). SBD-TMR and SBD-OG colocalize nearly completely
(,80%; data not shown), demonstrating that the fluorophore does
not influence the localization of SBD. SBD-TMR, SBD-OG, and
non-fluorophore tagged SBD also behaved similarly with respect
to their membrane-association properties in biophysical assays (see
section II, and Hebbar et al [51]).
The integrity of the SBD peptide after uptake was measured by
dot-blotting cell extracts of SH-SY5Y after uptake of a myc-tagged
version of the probe, and incubation with anti-myc (fig. S2). This
showed that 90% and 85% of SBD-myc were detectable after
30 min and 60 min post-5 mM incubation and chase, respectively.
This was comparable to the 87% and 86% of CtxB-peroxidase
that was detectable after 1 mg/ml incubation and 30 min or
60 min chase.
II. SBD binds to gangliosides in liposomes with raft-like
composition
Previously, we assessed SBD binding to various lipids by lipid-
protein overlay (fat-blot) assay, and found no detectable interac-
tion with glycosylated and non-glycosylated sphingoid bases,
sphingosylphosphocholine, ceramide, sulfatide, cholesterol, glycer-
ophospholipid, and myriocin [51]. In fat blots, SBD bound
gangliosides GM1, GD1a, GD1b, and slightly with SM [51].
However, we wished to assess binding to combinations of
sphingolipids and gangliosides in a more membrane-like setting
that would support microdomain formation.
To achieve this, we employed unilammelar liposomes of
,100nm average diameter, consisting of a raft-like base mixture
of POPC/SM/Chol (Palmitoyl-Oleoyl-Phosphatidyl-Choline/
Sphingomyelin/Cholesterol 45:25:30 mol%) [58], with various
components substituted, added, or subtracted. First, the require-
ment for SM and cholesterol was tested, with or without
galactosyl-cerebroside, which had been suggested to bind SBD
domains in general by Fantini et al [22]. After incubation with
SBD-TMR for 15 min at 37uC and filtration of the bound
liposomes, fluorescence remaining associated with the liposomes
was quantified by spectrofluorimetry, and the background level
(without liposomes) was subtracted. After background correction,
about six times more SBD-TMR was associated with the SM- and
cholesterol-containing liposomes than the POPC-only liposomes,
but this was not enhanced by the presence of 5% galactosyl-
cerebrosides (a mixture of single-galactose sphingolipids) (fig. 2A).
This is in contrast to the fat-blot assays [51], where galactosyl-
cerebrosides do bind strongly to SBD. We next left either
cholesterol or SM out of the mixture, showing that SBD required
both SM and cholesterol together for the best binding, although
SM alone provided some affinity (fig. 2B), in agreement with fat
blots [51]. Addition of 10% GD1a to the basic raft mixture
enhanced the binding still further (blue trace in fig. 2B).
To test whether SBD could bind to domains consisting of non-
sphingolipid saturated lipids, we combined the double-saturated
glycerophospholipid SPPC (Stearyl-Palmitoyl-Phosphatidyl-Cho-
line) with cholesterol in a POPC background, with or without
added 10% GD1a (fig. 2C). While the binding to POPC/SPPC/
Chol was slightly less avid than to the standard POPC/SM/Chol
mixture, addition of the glycosphingolipid drastically inhibited
binding, indicating that the interaction of SBD with glycosphin-
golipids is highly dependent on the simultaneous presence of SM.
Next, SBD’s preference for different concentrations of two
glycosphingolipids that had been reported to interact well with Ab,
GM1 and GD1a [46,48,59], was tested, and compared with the
binding of CtxB to the same two glycosphingolipids (fig. 3).
Marginally more SBD-TMR remained bound to liposomes that
contained a higher content of glycosphingolipid, up to 10% in the
spectrofluorimetric assay, and GD1a was slightly preferred over
GM1 (fig. 3D, E). SBD binding to gangliosides was also tested by
surface plasmon resonance (SPR) assay, using the Biacore 3000
and L1 Dextran-coated gold sensorchips (GE Healthcare) on
which the POPC/SM/Chol liposomes were immobilized. SPR
demonstrated much improved binding to 20% GD1a (fig. 3A, B).
This is in contrast to the binding behavior of CtxB-Alexa594,
which bound hardly better to GD1a than to no glycosphingolipid,
bound nearly maximally to only 5% GM1, and unlike SBD did
not detach (fig. 3C). By SPR, uncoupled SBD (fig. 3A) and SBD-
TMR (fig. 3B) gave very similar binding curves, suggesting that the
presence of the fluorophore on SBD does not drastically change its
binding properties. The binding affinity of SBD to 10% GD1a-
containing POPC/SM/Chol liposomes at pH 7 was calculated by
SPR to be between 2610
27 and 4610
26 (KD calculated from
fitting curves at various concentrations are shown in fig. S3). This
is similar to what has been reported for Ab1-40 [49].
Previous reports using SPR had found that binding of Ab(1–40)
to gangliosides increased with sialylation, i.e. that more highly
sialylated forms such as the GQ or GT series bound more tightly
[47]. In order to compare SBD’s binding preference for different
gangliosides, and the effect of pH on binding efficiency, liposomes
were made with the standard POPC/SM/Chol (45:25:30 mol%)
mixture plus 10% of GM1, GD1a, GD3, GT1b, or GQ1b, and
incubated with SBD at pH 5, 6, or 7 (fig. 4A–C). At neutral pH,
SBD bound better to the triply sialylated GT1b in comparison to
the less sialylated forms, GD3 (disialylated) and GM1 (mono-
sialylated). At lower pH (with an optimum at pH 5), binding to all
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in fig. 4D), and interestingly, interactions with less sialylated
gangliosides GM1 and GD1a became stronger.
Binding of SBD was also examined in the glycolipid-deficient
melanoma cell line GM95 [60], but was taken up very inefficiently
by both this cell line and its wild type parental line, B16 (not
shown). However, pharmacological inhibition of glycolipid
synthesis in SH-SY5Y using Fumonisin B1, which inhibits
ceramide synthase, did result in reduced binding and uptake of
SBD in neuroblastomas (described in [51]), indicating that
sphingolipids are necessary for uptake. The low level of labeling
seen in B16 and GM95 melanoma may represent the amount of
uptake that is mediated by the relatively weak interaction of SBD
with POPC, SM and cholesterol alone (see fig. 2, 3). Reports that
B16 melanomas produce almost entirely GM3 (,95%), with the
remainder consisting of GM2, GM1, and possibly GD1a [61]
support the conclusion that SBD indeed prefers high concentra-
tions of more complex ganglioside species (such as GT1b, GD1b,
or GQ1b; see fig. 4) in which this cell line is deficient.
III. The SBD uptake pathway is distinct from that of
known microdomain markers and Transferrin
In order to characterize SBD’s trafficking route, we carried out
time-course quantifications of SBD’s colocalization after pulse
chase labeling at physiological temperature, with respect to
reference microdomain-localized and endolysosomal markers.
Quantification was done using the colocalization algorithm of
Costes [62], to obtain the percentage intensity, from the Manders
coefficient (tM) [63] of the SBD signal over a given threshold that
is also positive for the reference marker (see Methods).
Because the V3 domains in Ab, Prp and HIV-gp120 were
reported to have a specific affinity for sphingolipids [22], in
particular glycosphingolipids containing a terminal galactose [42],
we asked whether SBD would occupy the same membrane
domains and follow the same endocytic pathways as previously
characterized markers that may also associate with glycosphingo-
lipids. Therefore, we first tested SBD colocalization in human
neuroblastomas over time with CtxB, a reagent commonly used as
an exogenous marker of glycolipid-containing domains [35].
In order to compare their trafficking routes, fluorescently
coupled CtxB-Alexa594 (Vybrant; Invitrogen) was applied after
initial incubation with SBD, and chased with fresh medium.
Colocalization of CtxB with SBD was minimal at early time points
in mammalian neuroblastomas (,5–10%; fig. 5A, C). After
uptake, the SBD-positive vesicles overlapped to a moderate degree
with CtxB (35–40% maximum; fig. 5C). Colocalization dropped
again precipitously after 1.5h, presumably due to targeting of CtxB
to the SBD-negative Golgi body. SBD showed no significant
colocalization with a marker of clathrin-mediated uptake,
Transferrin-Alexa594 [64,65] (fig. 5B, C).
The Flotillins are transmembraneproteins thatdefine a subtype of
non-caveolar cholesterol-dependent domain [66,67]. Flotillin2-GFP
[39] and SBD in neuroblastoma also colocalized minimally at
uptake, and converged at later time points (fig. 5D, E). Similarly,
Flotillin2-GFP colocalized initially very little with SBD in c6 cells,
but later colocalized substantially (45%; fig 5F, G). Flotillins are
taken up and trafficked independently from CtxB and GPI-GFP
[40,68], suggesting that the Flotillins, CtxB, and SBD each occupy
differentplasmamembranedomains.Thesemarkersalsousedistinct
classes of GTPases and/or combinations of accessory proteins for
their uptake (reviewed in [11]; D. Zhang & R. Kraut, in prep).
CtxB traffics to the Golgi body [35,69], whereas a substantial
portion of both SBD and Flotillinare targeted to late endosomes and
lysosomes (see section IV below; [40,68]). Consistent with this,
colocalization between SBD and Flotillin2-GFP is higher than that
between SBD and CtxB (fig. 5C, E). In summary, the colocalization
data with CtxB and Flotillin-2 indicate that these two labels initially
bind to different plasma membrane domains from SBD, but that
they subsequently converge to differing extents during sorting.
Lipid microdomains are formed in the Golgi and some proteins
that associate with membranes via a GPI-linkage are found in the
Golgi [35,70,71] (but see [36]). For this reason, we wondered
whether the SBD might also associate with the Golgi. SBD showed
little or no colocalization with a Golgi-specific antibody in c6 cells
(fig 5H).
Figure 2. SBD binds preferentially to glycolipid-containing liposomes with raft-like composition. A. Fluorescence retained on liposomes
of different composition after binding SBD-TMR to liposomes and filter-separation of unbound probe. SBD-TMR was retained much more strongly on
liposomes containing the raft-like mixture of POPC:SM:Ch (45:25:30) (black squares) than on liposomes composed only of POPC (green boxes).
Addition of 5% GCB (pink triangles), did not improve binding. B. A POPC/Chol (45:55) mixture (dark gray boxes) showed the lowest binding capacity,
whereas a POPC/SM (45:55) mixture bound with intermediate affinity (light gray boxes). This was further improved by the presence of cholesterol
(black boxes) and 10% GD1a (blue triangles). C. SBD shows some binding to the saturated glycerophospholipid SPPC, when substituted for SM in the
basic raft mixture (POPC:SPPC:Ch 45:25:30) (white boxes). Unlike SM containing rafts, however, binding is abolished by addition of 10% GD1a (blue
empty triangles). In all graphs, background fluorescence in the absence of liposomes, (e.g. due to possible retention of SBD in aggregated form) was
subtracted. In POPC/SM/Chol liposomes, background fluorescence accounted for ,25% of total signal.
doi:10.1371/journal.pone.0002933.g002
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late endolysosomes in neurons
After uptake in membrane domains, disparate endocytic
cargoes merge in an early sorting endosomal compartment [72–
75]. As a marker for this sorting domain, we used rab5-GFP
expressed in c6 neurons [76]. Shortly after application, SBD-TMR
often appeared surrounded by rings of rab5-GFP, indicating
uptake into a vesicular sorting compartment (Fig. 6A), consistent
with early colocalization values of ,45% (fig. 6B). SBD
colocalized maximally with the later endosomal-to-lysosomal
transport marker rab7-GFP [72,76] at a slightly later time point
than rab5-GFP (,45% at 1h; fig. 6E, F). FYVE-GFP, a marker of
sorting endosomes which also localizes to multivesicular endo-
somes [72,76], surrounded SBD-TMR in some cases, and
colocalization at moderate levels encompassed a longer time
frame from a presumptive sorting compartment (30 min; 30–35%)
to late endosomal compartments (1.5–2 h; ,25–30%)(fig. 6C, D).
After 3 h, SBD reached very high levels (65%) in a rab11-GFP
recycling compartment (fig. 6G, H).
Raft-borne sphingolipids such as sphingomyelin and glyco-
sphingolipids can be trafficked to the late endosome/lysosome,
where they are broken down [77–80]. For this reason, SBD-TMR
colocalization with markers of the late endolysosomal pathway was
tested. Since TMR is non-pH-sensitive, trafficking to acidic
compartments would be detected. As a marker for lysosomal
localization of SBD, we used Dextran10kDa-Alexa670 (Invitrogen)
incubated overnight. Consistent with Dextran being localized
exclusively in lysosomes or late endosomes, colocalization reached
its highest level from 2–4 h (30–35%; fig. 7A, B). We also
examined colocalization of SBD-TMR with the more broadly
distributed endolysosomal marker LAMP-GFP [81,82]. SBD
overlapped extensively with LAMP-GFP throughout the endoly-
sosomal trajectory, beginning in presumptive sorting endosomes
and peaking in late endosomes (15min–2h; fig. 7C, D). Notably,
the colocalization time-course of SBD with the acidic compart-
ment marker Lysotracker Red was low and slow compared to the
other endolysosomal markers, peaking after only 6–7 h at ,20%
(fig. 7E, F).
Figure 3. SPR (A–C) and spectrofluorimetric (D–F) binding assays of SBD-TMR to a POPC/SM/Chol (45:25:30 mol%) mixture show
that a high concentration of ganglioside (10–20%) is required for optimal binding, by comparison with CtxB to its target, GM1 (C,
F). A, B. Both non-fluorescently coupled SBD (A) and SBD-TMR (20 mM) (B) bind more strongly to 20% GD1a-containing POPC/SM/Chol liposomes
immobilized on a Dextran-coated L1 sensorchip. C. CtxB-Alexa488, in contrast to SBD, binds at a lower concentration (200 nM) with significantly
higher affinity. After the injection, CtxB showed nearly no dissociation from the liposome substrate, as indicated by a continued high response level.
D, E. Comparison between SBD-TMR (500 nM) binding to POPC/SM/Chol liposomes containing no ganglioside (black &) vs. GM1 (red N) or GD1a (blue
m), at 10% or 5% (D, E respectively) by spectrofluorimetric assay. F. Similar liposome assay as in D, E, with 100 nM of CtxB-Alexa binding to POPC/SM/
Chol liposomes with no ganglioside (black &) vs. 5% GD1a (blue m) or 5% of GM1 (red N). For spectrofluorimetric curves (D–F), the background
fluorescence in the absence of liposomes was substracted.
doi:10.1371/journal.pone.0002933.g003
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different neuronal cell types, human neuroblastoma SH-SY5Y and
mouse cortical neurons were labeled with Lysotracker and pulsed
with SBD-OG, showing extensive overlap (fig. 7G, H [not
quantified]; movie shown in fig. S4).
The relative localizations of the different available markers of late
endolysosomal/acidic compartments were compared by incubating
Lysotracker on cells whose lysosomes had been overnight labelled
with Dextran-Alexa488 (Dextran o/n), or transfected with LAMP-
GFP and pulsed with Dextran. As expected, lysotracker showed a
high tM with Dextran o/n (75.3% 64.3%), whereas the tM of
lysotracker with LAMP-GFP was lower (56.5% 62.5%) (Fig. 7I–L).
LAMP-GFP colocalized broadly with pulsed Dextran throughout its
trajectory (fig. 7J). This suggests that of the three lysosomal labels,
LAMP-GFP has the widest distribution spanning both late
endolysosomal and sorting compartments.
Figure 4. SBD preference for particular gangliosides depends on pH, and interaction with raft-ganglioside mixtures is strongly
enhanced at low pH. Spectrofluorimetric liposome binding assay of 100 nM of SBD-TMR with the raft-like ternary mixture POPC/SM/Chol
(45:25:30 mol%). 10% of the given ganglioside was incorporated into the lipid membrane: GM1 (red N), GD1a (blue m), GD3 (green m), GQ1b (black .)
and GT1b (cyan ¤). A, B and C are the fluorescence spectra taken at pH 7, 6 and 5 respectively. D summarizes the comparative fluorescence
responses at 580 nm for the various gangliosides at different pH.
doi:10.1371/journal.pone.0002933.g004
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like caveolin, but unlike the GEEC pathway (GPI-anchored-
protein-enriched Early Endosomal Compartment) [6] SBD is
sorted through a rab5-GFP-positive early endosomal compart-
ment. Thereafter, a portion of SBD traverses rab7-GFP-positive
late endosomes and may travel through FYVE-associated
multivesicular bodies, as has been reported for Ab [83]. Finally,
a large part of the SBD pool (,60%) reaches a recycling
compartment at a late timepoint (between 2–3 h), and the
remainder localizes to lysosomes labeled by Dextran.
V. SBD traffics similarly to Dextran and lactosyl ceramide
We tested SBD colocalization over time with pulse-chased
Dextran10kDa-Alexa670 (Dextran uptake in Drosophila haemo-
cytes has been described [84]), which at low concentrations is
incorporated into cdc42-dependent, non-clathrin associated endo-
cytic vesicles en route to lysosomes [36,84,85]. SBD colocalization
with Dextran ishigh (,60%)inpresumptiveearly endosomes at159,
drops in late endosomes (,40%) at 1–3 h, and rejoins Dextran in a
presumptive lysosomal compartment thereafter (,80%) (fig. 8A, B).
Corresponding to a tM value of 0.8, this is close to the maximum
seen in completely colocalizing controls (e.g. SBD-TMR+SBD-OG;
not shown). The dip in colocalization with Dextran at 1–3 h
corresponds to a sequential rise in colocalization with rab7 and
rab11 (fig. 6F, H). After diverging from the Dextran pathway at 1–
3 h, SBD then converges with Dextran in presumptive lysosomes
(see fig. 8B; see model,Fig. 7). A time-lapsemovie taken 90 min after
c6 neurons were labeled with both Dextran and SBD demonstrates
this phenomenon as SBD-carrying vesicles can be seen fusing with
Dextran-positive vesicles (fig. S5).
Several fluorescent sphingolipid analogs have been used as
tracers of endocytic trafficking pathways in cellular models of lipid
storage diseases [12]. Although N-acyl substituted analogs do not
behave in a manner completely analogous to endogenous
sphingolipids [86,87], certain species can be used as diagnostic
markers for trafficking defects [64,73,78,88,89]. Fantini and
colleagues have postulated that the V3 loop could interact with
the terminal galactose of glycosphingolipids and with sphingomy-
Figure 5. SBD trafficking converges to differing extents over time with lipid raft markers CtxB and Flotillin-GFP, but not with
clathrin-uptake marker Transferrin or Golgi. A. Colocalization of CtxB and SBD in SH-SY5Y neuroblastomas. CtxB-Alexa546 (red) was incubated
for 30 min in growth medium at 37uC, washed, then cross-linked with anti-CtxB (Vybrant, Invitrogen) for 15 min in growth medium at 37uC, and
washed. SBD-OG (green) was incubated immediately thereafter at 5 mM in growth medium for 10 min at 37uC. Both labels were chased in phenol-
red-free growth medium and imaged at the time-points given in graph (C). B. SBD does not colocalize with Transferrin (Tfn)-Alexa594, a marker of
clathrin-mediated uptake, in SH-SY5Y neuroblastomas. Cells were labelled with Tfn-Alexa594 (10 mg/ml) for 30 min at 37uC, washed, and incubated
with SBD-OG (5 mM) for 10 min at 37uC, both in growth medium. Scale bar=5 mm for A, B, D. C. Colocalization time-course of SBD-OG with CtxB (gray
bars) and Tfn-Alexa594 (black bars) in SH-SY5Y neuroblastomas. D. Flotillin2-GFP expressing SH-SY5Y neuroblastomas (green) were labeled 24h after
transfection with SBD-TMR as in (A). E. Quantification of Flotillin2-GFP vs. SBD-TMR in SH-SY5Y. F. Flotillin2-GFP expressing c6 cells (green) were
labeled 24h after transfection with SBD-TMR (10 mM) in growth medium for 15 min at 25uC. SBD-TMR (red) uptake vesicles are distinct from Flotillin2-
GFP vesicles in c6 cells, but increase in colocalization over time (graph in G). Cells were imaged between 60–90 min after application of labels in A–F.
Scale bar=2 mm. G. Quantification of Flotillin2-GFP vs. SBD-TMR in c6 cells. H. SBD shows virtually no accumulation in the Golgi body in c6 cells. C6
cells were labelled as above with SBD-TMR, chased, fixed, and stained with an anti-Drosophila Golgi antibody (Merck). Scale bar=2 mm.
doi:10.1371/journal.pone.0002933.g005
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interact more strongly with lactosyl-ceramide (gal-glc-Cer; lac-Cer)
or sphingomyelin than with other sphingolipid analogs. Therefore,
we were interested in testing the behavior of SBD with respect to
these markers.
In our hands, only fluorescent ceramide and lac-Cer analogs
were endocytosed by c6 cells. (A characterization of fluorescent
lac-Cer and ceramide trafficking in Drosophila cells will be
reported elsewhere (RH, EL, SH, SS and RK, submitted). SBD
showed the strongest colocalization of any marker throughout its
endocytic trajectory with BODIPY-lac-Cer (tMSBD 70%; fig. 8C,
D), which remains intact in c6 cells for up to ,14 h (ibid).
Strikingly, this co-trafficking of SBD and lac-Cer was only
observed when the two labels were present at the membrane
simultaneously, but not when they were added sequentially (fig. 8B,
‘‘simultaneous’’ vs. ‘‘sequential’’; see Methods). The effect was not
observed with Dextran, where SBD colocalization was similar
after simultaneous or sequential addition (not shown). Lac-Cer has
been reported to stimulate caveolar uptake [90], so the observed
strong colocalization of lac-Cer with SBD could reflect a
stimulation of endocytic uptake that carries both labels. However,
the fact that SBD never catches up with lac-Cer even after 14 h
suggests that a different mechanism is involved, perhaps a specific
interaction between SBD and the glycosphingolipid that influences
the trafficking pathway of one or both labels.
VI. SBD trafficking to lysosomes depends on cellular
cholesterol content
The formation of lipid microdomains, defined as more or less
transient regions of liquid ordered, saturated lipids in the
membrane, are thought to involve specific associations between
sphingolipids and cholesterol [4,88,91]. In keeping with SBD’s
interaction with membrane domains that depend on the presence
of cholesterol, we showed previously that its uptake is less efficient
and its diffusion at the membrane is faster after cholesterol
depletion with methyl-b-cyclo-dextrin (MbCD) [51]. The intra-
cellular trafficking of sphingolipid analogs is also known to be
affected by cholesterol overloading of mammalian fibroblasts and
neurons [12]. We therefore reasoned that SBD trafficking might
be altered by cholesterol depletion or excess if it is indeed acting as
a sphingolipid tracer. However, it was not clear that this would be
the case in Drosophila, since flies are cholesterol auxotrophs. In
order to test this, we depleted Drosophila c6 cells of cholesterol
and related sterols with MbCD treatment (see Methods), and
looked at the effect on SBD trafficking with respect to lysosomal
and endosomal markers. The effectiveness of the MbCD depletion
and cholesterol overload was confirmed (40% reduction in total
cholesterol after MbCD depletion; 250%, 613% increase after
overload; see [51]). SBD trafficking in mammalian neurons is also
affected by cholesterol manipulations, and will be presented
elsewhere (DZ, GT and RK, in prep).
SBD that was taken up in the cholesterol depleted c6 cells was
found to be trafficked to lysosomes somewhat less efficiently, based
on a lower than normal colocalization profile with Dextran-
labelled lysosomes, particularly at later time points (fig. 9A, B).
Under cholesterol overload (shown by filipin staining in and
around endolysosomal compartments; fig. 9C) SBD was actually
endocytosed more readily (quantification in fig. S6), but trafficking
was strongly perturbed. After uptake by cholesterol-loaded cells,
SBD was prematurely and abnormally trafficked to an acidic
lysotracker-positive compartment, and to Dextran-positive lyso-
somes, after only 15 min and 1 h, respectively. Colocalization with
both of these lysosomal markers dropped precipitously thereafter
to levels well below normal. This suggests that cholesterol excess at
the membrane and in endolysosomal compartments labelled by
LAMP-GFP (fig. 9C) may shunt SBD away from a sorting
Figure 6. Pulsed SBD-TMR traffics sequentially via rab5-, rab7-, and FYVE-positive vesicles to rab11 recycling endosomes in c6
cells. A, B. SBD colocalizes maximally with rab5-GFP positive early endosomes between 15 and 30 min. Cells were imaged 30 min after application of
SBD. C, D. SBD colocalizes maximally with FYVE-GFP positive sorting and multivesicular endosomes between 30 min and 2 h. E, F. SBD colocalization
with rab7-GFP positive late endosomes peaks at 1 h. G, H. SBD colocalizes strongly with rab11-GFP positive recycling endosomes only later, at 3 h.
For all labellings, SBD-TMR (10 mM in growth medium) was incubated at 25uC for 10 min on cells that had been transfected with the indicated
constructs 24–40 h earlier. Cells were imaged at 60 min after application of SBD-TMR in C, E, and G.
doi:10.1371/journal.pone.0002933.g006
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divert it away from the lysosomal pathway.
Discussion
This report presents the characterization of a fluorescently
tagged peptide probe, the SBD, for tracing the trafficking
pathways of sphingolipid-containing membrane microdomains in
living cells. We present evidence that SBD binds to artificial
membranes with raft-like composition, with improved binding
efficiency at low pH and in the presence of gangliosides.
Quantitative time-course colocalizations based on the method of
Costes [62] are used to describe the endocytic trafficking pathway
of fluorescently tagged SBD, and compare its intracellular
trajectory with those of other presumptive microdomain-specific
and endolysosomal markers.
Consistent with the model of Fantini et al, wherein aromatic
and basic residue(s) in the SBD were proposed to interact with
galactose-terminal glycolipids and sphingomyelin, we found that
SBD-TMR interacted optimally with the combination of POPC/
SM/Chol, and the strongest enhancement of binding was seen
when ganglioside was added to this mixture. The ability to bind
POPC/SM/Chol may be partially attributable to the tendency of
this mixture to phase separate into liquid ordered domains
(confirmed by atomic force microscopy [GT & RK, unpublished
results]; [58]), since a saturated glycerophospholipid with the same
choline headgroup (SPPC), which would also be expected to phase
separate, was able to substitute for sphingomyelin to some extent.
Figure 8. SBD-OG traffics similarly to pulsed Dextran-Alexa670 and lactosyl-ceramide when both labels are present simultaneously
at the plasma membrane. A, B. SBD-OG follows a similar pathway to Dextran-Alexa670 (shown after 159, 1 h, and 20 h), but appears to diverge
transiently in post-sorting late endosomes between ,60 min and 3 h (see movie S3). Cells were incubated first with SBD-OG at 5 uM in HBSS for
15 min at 25uC, washed once, and incubated in Dextran-Alexa670 at 0.5 mg/ml in HBSS for 5 min, washed, chased in HBSS, then imaged at the time-
points given in the graph (B). C, D. BODIPY-lac-cer (red) shows nearly complete colocalization with SBD-OG (green) when incubated simultaneously
on c6 neurons (gray bars; see Methods). Sequential incubation (black bars) leads to much lower colocalization scores. Even after 14 h, colocalization
levels never approach those attained with simultaneous incubation, indicating an altered trafficking route taken by at least one of the two labels. For
simultaneous SBD/lactosyl-Ceramide labellings, cells were incubated with lactosyl-Ceramide (5 mM at 4uC for 30 min, washed once, incubated with
SBD-OG (25uC as in A), chased in HBSS, and imaged at the time-points given in graph (D). For sequential labellings, cells were incubated with BODIPY-
lac-cer at 25uC, washed several times in warmed HBSS to allow uptake, then incubated with the second label (SBD-OG) at physiological temperature
(concentrations as above), washed in HBSS, and chased in growth medium. Scalebar=5 mm.
doi:10.1371/journal.pone.0002933.g008
Figure 7. SBD traffics slowly to endolysosomes in c6 cells (A–E) and is found in lysotracker-positive compartments of mammalian
neurons (G, H). A, B. Pulsed SBD-OG (green) (incubated at 5 mM in growth medium at 25uC for 10 min) reaches Dextran-Alexa670 (0.5 mg/ml; red)
labelled late endolysosomal compartments maximally after 2 h of chase in growth medium. C, D. SBD-TMR (red), incubated at 10 mM in growth
medium 24 h after transfection with LAMP-GFP (green) colocalizes maximally in presumptive sorting and late endosomal compartments, up to 2 h of
chase in growth medium. E, F. SBD-OG (green) (incubated as in A, B) colocalization with lysotracker (red) (incubated at 75 nM 2 h at 25uC) peaks
transiently in a late endosomal compartment (2 h) before reaching a moderate maximum (,20%) only after 5–7 h (see control graph in fig. 7A). Cells
were imaged between 60–90 min after application of SBD in A–E. G, H. SBD-OG (green; incubated at 2 mM for 15 min at 37uC) also colocalizes
extensively with lysotracker in SH-SY5Y neuroblastomas, and in mouse primary cortical neurons, shown at 60 min after application of SBD (incubated
at 75 nM 2 h at 37uC for both; movie of neuroblastomas shown in fig. S3). I–L. Relative distributions of different endolysosomal markers in c6 cells. (I)
Lysotracker (red; labelled as in E) and Dextran-Alexa488 (incubated at 0.5 mg/ml for 5 min at 25uC) chased overnight (green) colocalize ,75% (L), but
some Dextran vesicles are not acidic, indicated by the absence of lysotracker (arrowhead). J. Pulsed Dextran-Alexa670 (incubated as in I, 24 h after
transfection) colocalizes with LAMP-GFP throughout its trajectory, reaching maximum tM ,45% (also see Sriram et al, 2003). K, L. Transfected LAMP-
GFP labels both acidic and non-acidic vesicles, as judged by substantial non-colocalization with lysotracker-red (incubated as in E). Scalebar in all
images=5 mm.
doi:10.1371/journal.pone.0002933.g007
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that which was seen with sphingomyelin. Moreover, addition of
glycosphingolipid to the SPPC mixture abolished binding, whereas
it strengthened the binding of the sphingomyelin mixture.
Therefore, although an interaction with other PC-containing
liquid ordered domains is possible, it appears likely that under
conditions at the plasma membrane of a cell, where glycolipids are
present, a PC-headgroup sphingolipid (i.e. sphingomyelin) is
strongly preferred.
SBD showed a preference for multiply sialylated gangliosides at
neutral pH, similarly to amyloid peptide Ab1240 [47,49], but the
specificity for a particular ganglioside is less strict than is the case
with CtxB. Interestingly, the strength of SBD’s interaction with
ganglioside-containing membranes is greatly enhanced at low pH.
Because of this, one can speculate that as SBD is endocytosed and
the pH drops, its interaction with the membrane may be
strengthened by masking of electrostatic repulsion between SBD
(which has a pKa of ,4.25) and sialic acid. Given the overall
negative charge of SBD, however, its predilection for GT1b,
GQ1b, and GD1a (which have multiple sialic acids) over GM1
(which has one) at pH 7 is difficult to explain. Possibly, the
positively charged Arg and His residues near the aromatic Tyr
residue proposed by Fantini to be important in binding via p-
bonding interactions [1], actually attract SBD to more heavily
Figure 9. SBD trafficking to acidic organelles is sensitive to cholesterol levels. A. C6 cells depleted of cholesterol with MbCD (10 mM
30 min 25uC; red circles) or treated with excess cholesterol (10 mM MbCD-10mM cholesterol complexes for 30 min 25uC; blue triangles), or untreated
(black squares), then labeled with lysotracker and pulsed with SBD-OG. Colocalization (tMSBD) was calculated at the given time points of chase. Data
for control untreated cells were compiled from two experiments. B. C6 cells were labeled with Dextran-Alexa488 overnight, and then depleted of
cholesterol (red circles), or treated with excess cholesterol as in (A)(blue triangles), or untreated (black squares) and labeled with SBD-TMR, as in fig. 5F.
Colocalization was calculated at the given time points of chase. C. Control c6 cells (top panels), or c6 treated with excess cholesterol (bottom panels)
after transfection with LAMP-GFP (green) and subsequent fixation show heavy accumulations of filipin (pink) at the plasma membrane and near, but
not exclusively in, endolysosomal compartments (brackets). Total cholesterol content after cholesterol overloading was increased by 250%, 613%
(n=3; quantification by Amplex Red enzymatic assay not shown). Scale bars for all images=5 mm. D. Schematic representation of the internalization
pathway of fluorescent SBD (red shapes) vs. another lipid-raft associated cargo, CtxB (blue hexagons), which is taken up by the GEEC pathway [11].
Cholesterol depletion moderately inhibited transport of SBD through a Dextran-positive lysosomal compartment (.90 min in graph B), whereas
cholesterol excess led to premature accumulation and then clearing of SBD from lysotracker- and Dextran-positive acidic compartments. Detection of
myc immunoreactivity indicates that internalized SBD-myc has not been degraded. Dot blots were also exposed to anti-b-tubulin as a loading control
to ensure that protein amounts were comparable in the various sets. Intensity of dots was quantified using Quantity One software and represented in
bar graphs.
doi:10.1371/journal.pone.0002933.g009
SBD Probe Traces Raft Traffic
PLoS ONE | www.plosone.org 11 August 2008 | Volume 3 | Issue 8 | e2933sialylated gangliosides. This would be supported by the work of
Ariga et al [47], and by our experiments at neutral pH. On the
other hand, SBD’s preference for less sialylated glycolipids (e.g.
GM1) in acidic endosomes suggests the possibility that Fantini’s
proposed p-bonding with the exposed galactose, or a specific
structural interaction with terminal galNAC-gal-sialic acid, may
begin to dominate when the charges are neutralized.
Confirming the spectrofluorimetric liposome binding assays
above, SPR analysis showed improved binding of SBD-TMR to
the same liposomes immobilized on a Dextran-coated gold chip, as
the concentration of GD1a was increased. However, we note that
binding of SBD reacted relatively weakly and gradually to low
concentrations of ganglioside, and required up to 20% to give the
maximal response, as compared to CtxB, which bound very
strongly already at just 5% GM1. These results together with the
lack of intracellular colocalization with CtxB (below) suggest that
recognition of different glycolipids (in this case GD1a vs. GM1),
perhaps in combination with membrane proteins, may mediate
uptake into distinct intracellular trafficking routes, as suggested by
Lencer and colleagues [92].
As would be expected for a raft-binding probe [1], SBD showed
no detectable colocalization with Transferrin, which is internalized
by clathrin-mediated endocytosis [74]. Unexpectedly, however,
SBD showed only low to moderate overlap upon uptake and
trafficking in neuroblastomas with the sphingolipid-interacting
marker CtxB. In some mammalian cell types, CtxB is thought to
follow a cdc42-dependent uptake pathway [36,40,72,93] but it can
also be endocytosed by a mixture of non-clathrin and clathrin-
mediated mechanisms in neurons [28–30,93,94]. SBD showed
higher colocalization with another raft-localized marker, Flotillin2-
GFP which, like SBD, traffics to a large extent through the
endolysosomal pathway [40,68].
The non-colocalization with CtxB was all the more surprising,
because of reports that Ab (from which SBD is derived) binds to
the same glycosphingolipid as CtxB, namely GM1 [21,95,96]. Ab,
however, can also bind to other glycosphingolipids, dependent on
conformation [47,49]. From these results we conclude that SBD is
internalized by a non-clathrin pathway that is distinct from other
cholesterol-dependent pathways, reflecting the probable heteroge-
neity of lipid microdomains as has been noted in many other
studies [10].
After uptake, SBD overlapped extensively with the endolysosomal
tracer Dextran, which at low concentrations is endocytosed via a
cdc42-dependent uptake pathway [40,85,93]. Early, SBD trafficked
through a rab5RFYVERrab7 trajectory, finally reaching lysosomes
after 3–4h(summarized infig.9D). A significantamount (tM ,60%)
of SBD also trafficked from late endosomes (1.5–2 h) to a rab11-
GFP-positive recycling compartment, which has been reported to be
particularly rich in sphingomyelin and cholesterol in mammalian
cells [26,77,97,98]. These findings are interesting with regard to the
discoverythat mutations inAlzheimer’s disease-linked SORL1 result
in shunting of App away from recycling endosomes toward the
endolysosomal pathway [99,100]. More experiments will be
required to determine whether and how App trafficking and SBD
trafficking are related.
Of all the markers tested, the highest degree of colocalization
was found between SBD and the glycosphingolipid analog
BODIPY-lac-Cer. Interestingly, this was only true when the two
labels were present at the membrane simultaneously; sequential
addition resulted in nearly no colocalization. The finding that SBD
and lac-Cer trafficked so closely together was surprising, since lac-
Cer’s trafficking itinerary is different from that of SBD in both
mammalian [78,101] and Drosophila cells (RH, EL, SH, SS &
RK, submitted). Their co-trafficking may result from SBD’s
affinity for glycosphingolipids, or may reflect a phenomenon we
have documented in a separate study, termed ‘‘hijacking’’,
whereby one label influences the trafficking behavior of the other.
The hijacking mechanism is apparently different from the simple
stimulation of uptake reported by Pagano and colleagues [90],
since we find that even over extended chasing times, the second
label added sequentially never reaches the same compartment as
the first, which would be expected if only endocytic stimulation
were responsible (RH, EL, SH, SS & RK, submitted).
The interaction of SBD with glycosphingolipids is consistent
with our finding that its trafficking to lysosomes is strongly affected
by cholesterol levels, since glycolipids are also known to traffic
aberrantly in cholesterol storage disease fibroblasts [12]. Paradox-
ically, however, we find that SBD trafficking to the lysosome is
ultimately diminished by excess cholesterol, in contrast to
glycosphingolipids, which accumulate to excess in endolysosomes
under similar conditions. In summary, it appears that SBD
trafficking is strongly influenced by cellular cholesterol levels,
especially cholesterol overload, and this may reflect an underlying
event involving the trafficking of its glycosphingolipid partner(s).
Moreover, changes in SBD targeting may provide insights into the
effects of cholesterol perturbation on the trafficking behavior of
Ab, since their binding characteristics appear to be similar.
Conclusion
In this study, we describe the intracellular trafficking of a novel
fluorescent sphingolipid-interacting marker, the SBD, and present
evidence that it can interact with raft lipids sphingomyelin,
cholesterol, and glycosphingolipids, but without a highly specific
interaction to a particular ganglioside, like CtxB. Thus, SBD can
potentially be used to trace the intracellular pathways of sphingo-
lipid-containingdomains,includingatleastsomegangliosides.There
is little doubt about the utility of being able to follow the trafficking
routes of sphingolipids and microdomains in living cells, yet very few
non-transgenic probes are currently available that track these lipids.
The SBD probe is a short, non-toxic peptide, and can therefore
be produced easily as a fluorophore-linked conjugate and applied
exogenously to cells. Together with the observation that SBD’s
trafficking route reacts strongly to cholesterol perturbation, these
properties make it well suited for applications in diagnostic and
drug screening assays. Additionally, the fact that SBD behaves
similarly in Drosophila and mammalian neurons validates its use
as a tool for studying lipid trafficking disease models in the fly.
Further characterization of the behavior of the SBD in the context
of genetic and lipid perturbations will allow the use of this probe in
models of neurodegenerative and other diseases that are linked
with the metabolism and trafficking of sphingolipids. Information
gained from such studies would contribute to our understanding of
the involvement of sphingolipid trafficking in neurodegenerative
disease pathologies.
Materials and Methods
Cell culture
Growth media: Drosophila neuronal cell lines DL-DMBG2-c6
(Drosophila Genome Resource Center; Ui et al, 1997) were grown
at 25uC in Schneider’s medium (Gibco, USA) with 10% fetal
bovine serum (FBS; Gibco, USA), 0.125IU/ml bovine insulin
(Biological Industries, Israel), and 1% antibiotic/antimycotic
solution (Gibco, USA). NIH3T3 mouse fibroblasts and SH-
SY5Y neuroblastoma (ATCC, USA) were grown at 37uCi n
Dulbecco’s Modified Eagle’s Medium (DMEM; Gibco, USA) and
DMEM/F12 (Gibco,USA)respectively, both with 10% FBS and
1% antibiotic.
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the papain disassociation technique described previously [55] and
cultured on 8-well, coverglass-bottom dishes for 3–7 days prior to
analyses.
Production of fluorescently tagged SBD peptide, cell
labelling, and degradation assays
SBD peptide preceded at the N-terminus by two copies of an inert
spacer([AEEAc]2)wasconjugatedtoOregonGreen (OG)viaa thiol
linkage to an N-terminal Cysteine, or Tetramethylrhodamine
(TMR) via an amide linkage directly to the spacer, was synthesized
by Bachem, Switzerland, such that the final sequences were OG-
Cys-[AEEAc]2-DAEFRHDSGYEVHHQELVFFAEDVG, and
TMR-[AEEAc]2- DAEFRHDSGYEVHHQELVFFAEDVG, re-
spectively. A mutated sequence (DAEFAHDSGAEVHHQELVF-
FAEDVG) and a scrambled sequence (FYHDESEFGHA-
VEQFGRDVEAVHDL) were also coupled to the fluorophores
and to myc as controls. To avoid aggregate formation of the peptide,
SBD was dissolved in 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP)
(Lancaster, UK), aliquoted and dried. Lyophilized peptide was
stored at 220uC, and redissolved immediately before use in DMSO.
Peptide was diluted to a final working concentration of 10 mMi n
Hanks Buffered Salt Solution (HBSS; Gibco) supplemented with
10 mMHydroxyethylpiperazine-ethanolsulfonicacid(HEPES) orin
growth medium, and incubated at 25uC for 15 min at 10 mMo r
5 mM (for SBD-TMR and SBD-OG respectively, on c6 cells) or
37uCa t2mM (for mammalian cells), and then washed three times in
HBSS/HEPES (for double labellings with lipid analogs), or growth
medium (for double labellings with other markers).
Conjugation of SBD was confirmed by HPLC and mass
spectrometry by the manufacturer (Bachem AG, Bubendorf,
Switzerland); HPLC and MS peaks showed no change in structure
of the peptide, and elution at the expected molecular weight.
Additional confirmation of the conjugation efficiency of SBD to
fluorescent labels was carried out by fluorescence correlation
spectroscopic (FCS) measurement of diffusion times of the
uncoupled fluorescent label diluted to ,1 nM. A confocal Zeiss
Axiovert 200 microscope combined with Igor Pro Software
(Wavemetrics) was used for FCS measurements, which were run
in multiples of 5 sets each lasting for 30 sec. The obtained
correlation functions were fitted, corresponding parameters
calculated and finally averaged.
To test whether SBD was degraded after uptake in cells, SH-
SY5Y neuroblastoma were incubated with 5 mM Myc-tagged
SBD (synthesized by GenScript Corp, New Jersey) for 10 min, and
then replaced with fresh medium. After 10, 30, and 60 min chase,
cells were lysed in Tris-NaCl, EDTA buffer with 0.5% Triton-
X100. Lysates with equal amounts of protein (estimated by BCA
assay) were blotted onto nitrocellulose membranes for dot blots.
The same procedure was carried out for peroxidase-conjugated
CtxB (1 mg/ml) as a control. After blocking, membranes were
exposed to peroxidase-conjugated anti-myc (Santa Cruz) and blots
were developed using chemiluminescence.
Cell labelling with fluorescent lipid analogs and
endolysosomal tracers
Cells were seeded at a density of 10
6 cells/ml into either 8-well
chambers with 0.17 mm coverslip bottoms (Nunc, Denmark) or
25 mm dishes with coverslip bottoms (Fluorodishes; WPI).
Experiments were conducted 24–72 h post-seeding. Before
addition of fluorescent lipid analogs, cells were washed 3 times
with HBSS/HEPES, unless otherwise stated. The following lipid
analogs with attached 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
(BODIPY) fluorophore were from Molecular Probes (Invitrogen):
BODIPY-C5-ceramide, BODIPY-FL-C12-Sphingomyelin, BOD-
IPY-FL-C5-lactosylceramide. Cells were washed with pre-chilled
HBSS/HEPES, incubated with 5 mM lipid for 30 min at 4uC,
washed with ice-cold HBSS/HEPES and chased for various times
with fresh growth medium supplemented with 1% Oxyrase
(Oxyrase, Inc., USA) at 25uCo r3 7 uC.
Lysotracker staining of acidic compartments was done by
incubating cells for 2 h with 75 nM Lysotracker Red (Invitrogen)
in normal growth medium.
Alexa594- or Alexa546-coupled Cholera Toxin B (CtxB)
(Vybrant kit; Invitrogen) was incubated at 5 mg/ml in growth
medium for 30 min at 37uC on neuroblastoma cells, washed, and
cross linked with anti-CtxB antibody provided in the kit (5 mg/ml
in growth medium) for 15 min at 37uC. For double labelling with
SBD-OG, at this point 5 mM SBD in growth medium was added
for 10 min at 37uC, washed, and imaged at various time-points
after chasing with 37uC growth medium.
For double labellings of neuroblastoma cells with transferrin
(Tfn), Tfn-Alexa594 (Invitrogen) was incubated in growth medium
at 10 mg/ml for 30 min at 37uC, washed, and incubated in SBD-
OG at 2 mm/ml for 10 min in growth medium, washed, and
chased in growth medium.
For pulse labelling c6 cells with Dextran, cells were incubated
for 5 min at 25uC with 0.5 mg/ml Alexa488- or Alexa670-
Dextran (10,000MW; Invitrogen) in HBSS/HEPES, washed with
HBSS/HEPES, and imaged after various chasing times.
Simultaneous vs. sequential labelling
For SBD/Dextran double labellings described as ‘‘simulta-
neous’’, the cells were incubated with SBD for 15 min, washed
quickly once, then incubated with Dextran for 5 min, chased with
fresh medium and imaged immediately. For simultaneous SBD/
lactosyl-Ceramide labellings, cells were incubated with lactosyl-
Ceramide at 4uC for 30 min, washed once, incubated with SBD
for 15 min in HBSS at 25uC such that both labels would be
present at the plasma membrane simultaneously at the beginning
of the time-chase with fresh growth medium. For ‘‘sequential’’
labellings, cells were incubated with the first label at physiological
temperature, washed several times in warmed HBSS to allow
uptake, then incubated with the second label at physiological
temperature, washed in HBSS, and chased in growth medium.
Production and labeling of liposomes
Liposomes were prepared from a ternary mixture of 45% 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar Lip-
ids, Alabaster, AL), 25% sphingomyelin (bovine brain; Sigma) and
30% cholesterol (Sigma). Bovine brain derived monosialoganglio-
side GM1 (Avanti Polar Lipids) and GD3 (Accurate Chemical &
Scientific, Westbury, NY), disialoganglioside GD1a (Sigma),
trisialoganglioside GT1b (Sigma), and tetrasialoganglioside
GQ1b (Accurate Chemical & Scientific) were incorporated into
the initial lipid mixture in the desired ratios. The lipids were
dissolved in chloroform: methanol, 2:1 (v/v), dried by vacuum
rotary evaporation in a round-bottom flask partially submerged in
a4 2 uC water bath subsequently dried overnight in a vacuum
chamber. The dry lipids were hydrated in HBSS/HEPES for 2 h
at 60uC to 0.5 mg/ml, reduced to ,100 nm average diameter by
sonication. and filtered through a 0.2 mm polycarbonate. This
liposome solution was stable at 4uC for several months.
SBD-TMR or CtxB-Alexa594 was added to 500 mL, 0.1 mg/
mL liposome solution and incubated for 30 min in Omega
Nanosep 300K MWCO centrifugal devices (Pall Life Sciences,
Ann Arbor, MI). The unbound SBD peptides were separated by
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were resuspended in 500 mL HBSS/HEPES and fluorescence
measured with Fluorolog spectrofluorometer (Horiba Jobin Yvon,
Edison, NJ) at 543 nm excitation for TMR and 594 nm for Alexa.
Surface Plasmon Resonance
All measurements were carried out at 25uC in 10 mM HEPES,
pH7.4, 150 mM NaCl buffered saline. L1-sensorchip surface was
cleaned by an injection of 40 mM 3-[(3cholamidopropyl)
Dimethylammonio]-1-propane sulfonate (CHAPS, Ambresco),
followed by 20 mM n-Octyl b-D-glycopyranoside (Sigma) and
CHAPS. The cleaned Dextran-surface was coated with 50 mL
liposome solution at a flow rate of 2 mL/min. Unbound liposomes
were removed with a short pulse of 10 mM NaOH. 5 mL of 1 mg/
mL BSA was injected to block unbound Dextran. After rinsing the
surface, SBD or CtxB was injected into the flow cells at 10 mL/
min at 20 mM and 0.2 mM, respectively. The chip was
regenerated with 80 mL 40 mM CHAPS.
Transfection of neuronal cells and DNA constructs
The following DNA constructs were used: pUAST-GFP-LAMP;
Flotillin2-GFP was excised from pAc5.1(A)Flotillin2-EGFP [39]
and subcloned into pCDNA3.1 (Invitrogen). Transfection was
performed using Lipofectamine 2000 (Invitrogen) as per manu-
facturer’s instructions, and subsequent labelling and imaging was
carried out between 24–40 h post-transfection.
Cholesterol depletion and overload
Cells were incubated in 10 mM Methyl-b-cyclo-dextrin
(MbCD) (Sigma, USA) for 30 min in serum-free medium, and
washed. Cholesterol concentration in cell extracts was measured
using Amplex Red Cholesterol Assay kit (Invitrogen), and
normalized to protein concentration. For cholesterol excess,
10 mM MbCD:10 mM cholesterol complexes were prepared as
in Klein, et al[102] and incubated with cells at 25uC for 30 min
before labelling. Treated cells were further incubated in complete
medium with FBS.
Immunocytochemistry and cell viability assays
The following antibodies were used: anti-Drosophila Golgi
(Merck), 1:250; Alexa488, 568, or 633-coupled secondaries
(Invitrogen). Cell viability was confirmed using Sytox Green
(Invitrogen) as per manufacturer’s instructions.
Imaging and Image processing
Confocal images were obtained on Zeiss LSM510, Leica TCS
SP2, and Olympus FV300 microscopes with a 63x/1.4NA oil
objective (LSM510, TCS SP2), 60 X/1.4NA oil objective (FV300),
or 63x/0.9NA dipping lens (TCS SP2). For double labelling, each
fluorescent dye tested for crosstalk into other channels, and different
channels were acquired sequentially, with a pinhole diameter of 1
airy unit. Movie in fig. S3 was acquired with a CoolsnapHQ CCD
camera on a Deltavision (Applied Precision) widefield microscope
with a 60X/1.42NA oil lens (Olympus) and a standard (green
ex490/20, em528/38; red ex555/28,em617/73)filter set (Chroma).
SigmaPlot (Systat) and Origin were used to create charts and
graphs and figures were assembled in Adobe Photoshop 7.0.1
(Adobe Systems, Inc). Image analysis was performed using ImageJ
(rsb.info.nih.gov/ij) with the plugins: ‘‘Colocalization Test’’ and
‘‘Colocalization Threshold’’ by T. Collins and W. Rasband, ‘‘BG
Subtraction from ROI’’ by M. Cammer and T. Collins (www.
uhnresearch.ca/facilities/wcif/imagej). For live/dead assays cells
were counted manually using the ImageJ ‘‘Cell count’’ plugin.
Colocalization was quantified using the thresholding algorithm
of Costes et al [62] on background corrected images. Random-
izations were done with 25 iterations (Colocalization Test plugin).
If colocalization test resulted in no significant difference between
randomized and original images (P,0.95), no colocalization was
assumed. If colocalization was significant (P.0.95) the second
plugin ‘‘Colocalization threshold’’ was applied to determine
colocalization parameters. Colocalization was expressed as tMSBD
(a fraction between 0 and 1), the Manders coefficient for the SBD
channel calculated with the thresholding algorithm of Costes et al.
Each data point consisted of two separate experiments, taking into
account at least 10 cells each.
Supporting Information
Figure S1 SBD treatment of cells does not affect cell viability at
working concentrations (2–10 mM). Percentages of Drosophila c6
neurons negative for Sytox Green (Invitrogen) are shown for cells
labeled with SBD (black bars) or SBD* (gray bars) at the indicated
concentrations.
Found at: doi:10.1371/journal.pone.0002933.s001 (0.21 MB DOC)
Figure S2 SBD is detectable by dot blots after 60 minutes of
chase after uptake. SBD-myc levels in cell lysates of SH-SY5Y
neuroblastoma after 10, 30, and 60 minutes of post-incubation
chase are comparable on dot blots to levels of CtxB-peroxidase
after similar labelling and chase in the same cell line. Quantifi-
cation of myc intensity levels (see graph) indicates that 85% of
SBD-myc is detectable after 60 minutes chase. Intensity levels are
normalized to tht after 10 minutes chase. 86% of CtxB is
detectable 60 minutes post-incubation. Detection of myc immu-
noreactivity indicates that internalized SBD-myc has not been
degraded. Dot blots were also exposed to anti-b-tubulin as a
loading control to ensure that protein amounts were comparable
in the various sets. Intensity of dots was quantified using Quantity
One software and represented in bar graphs.
Found at: doi:10.1371/journal.pone.0002933.s002 (3.21 MB TIF)
Figure S3 Titration curves used to calculate the binding affinity
(KD) of SBD to raft-like membranes. Response signals of SBD
peptide injected at various concentrations between 0.5 mM and
50 mM over a surface homogeneously covered with POPC/SM/
Chol+10% GD1a liposomes. Best fit was obtained with a
heterogeneous ligand model (black curves). The bulk refractive
index (RI) was calculated separately contributing different bulk
shift effects at the beginning and end of the injection.
Found at: doi:10.1371/journal.pone.0002933.s003 (6.03 MB TIF)
Figure S4 Movie showing SBD (green) incorporation into motile
endolysosomal compartments of SH-SY5Y neuroblastomas la-
beled with Lysotracker (red). Movie was taken by widefield
fluorescence microscopy, and spans 5.7 min of real time, 30 min
after SBD labelling (2 mM, 15 min, 37uC), at 1.2 sec/ frame, and
assembled at 30 fps.
Found at: doi:10.1371/journal.pone.0002933.s004 (4.41 MB MOV)
Figure S5 Movie showing SBD-OG (green; incubated for
15 min at 5 mM, 25uC)) and Dextran-Alexa670, 10kDa (blue) in
Drosophila c6 neurons after 90 min chase, when colocalization
drops to a moderate level (,40%). SBD-carrying vesicles can be
seen fusing with Dextran-carrying vesicles in three of the cells
shown, which may represent fusion in late endolysosomal
compartments. Individual confocal fluorescence images were
collected every 1 sec over 1 min 15 sec of real time, and assembled
at 30fps.
Found at: doi:10.1371/journal.pone.0002933.s005 (0.07 MB MOV)
SBD Probe Traces Raft Traffic
PLoS ONE | www.plosone.org 14 August 2008 | Volume 3 | Issue 8 | e2933Figure S6 Uptake of SBD-TMR (incubated at 10 mM, 15 min,
25uC) after cholesterol overloading of c6 cells with MbCD-
cholesterol complexes, assessed by measurement of total intracel-
lular fluorescence intensity in 25 cells per time point up to 2 h after
labeling, and expressed as average fluorescence intensity per pixel
(quantitation was done as in Cheng et al (Cheng et al., 2006).
Uptake is slightly increased in cholesterol overloaded cells (gray
bars) over control cells (black bars).
Found at: doi:10.1371/journal.pone.0002933.s006 (0.60 MB DOC)
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